These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 16476851

  • 1. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW.
    Circulation; 2006 Feb 21; 113(7):977-85. PubMed ID: 16476851
    [Abstract] [Full Text] [Related]

  • 2. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M.
    Rom J Intern Med; 2009 Feb 21; 47(1):35-40. PubMed ID: 19886067
    [Abstract] [Full Text] [Related]

  • 3. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N, Christchurch Cardioendocrine Research Group, Australia-New Zealand Heart Failure Group.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):52-60. PubMed ID: 16386664
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM.
    Heart; 2008 May 03; 94(5):617-22. PubMed ID: 17639095
    [Abstract] [Full Text] [Related]

  • 5. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct 03; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 6. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T.
    Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065
    [Abstract] [Full Text] [Related]

  • 7. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y, Hamada M, Ohtsuka T, Ogimoto A, Saeki H, Matsunaka T, Suzuki J, Shigematsu Y.
    Heart Vessels; 2002 Dec 10; 17(2):53-6. PubMed ID: 12541094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G.
    Kardiol Pol; 2009 Mar 10; 67(3):254-61. PubMed ID: 19378231
    [Abstract] [Full Text] [Related]

  • 10. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB, Bacevicius E, Bech JN, Solling K, Pedersen HB.
    Clin Sci (Lond); 2006 Apr 10; 110(4):491-501. PubMed ID: 16396628
    [Abstract] [Full Text] [Related]

  • 11. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H, Pedersen RS, Pedersen HB, Nyvad O, Pedersen EB.
    Clin Sci (Lond); 2003 Mar 10; 104(3):303-12. PubMed ID: 12605591
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ.
    Clin Sci (Lond); 2004 Feb 10; 106(2):129-33. PubMed ID: 13678415
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.
    Crit Care Med; 2006 Aug 10; 34(8):2140-4. PubMed ID: 16763507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
    Berger R, Huelsmann M, Strecker K, Moertl D, Moser P, Bojic A, Pacher R.
    Eur J Clin Invest; 2005 Jan 10; 35(1):24-31. PubMed ID: 15638816
    [Abstract] [Full Text] [Related]

  • 17. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.
    Frankenstein L, Nelles M, Slavutsky M, Schellberg D, Doesch A, Katus H, Remppis A, Zugck C.
    J Heart Lung Transplant; 2007 Oct 10; 26(10):1033-9. PubMed ID: 17919624
    [Abstract] [Full Text] [Related]

  • 18. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D.
    Eur J Cardiothorac Surg; 2007 May 10; 31(5):922-8. PubMed ID: 17321144
    [Abstract] [Full Text] [Related]

  • 19. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T, Funayama H, Yoshimura A, Tsuruya Y, Saito M, Kawakami M, Ishikawa SE.
    Int J Cardiol; 2006 Jan 13; 106(2):191-5. PubMed ID: 16321691
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.